60m-dollar

Teva targets 60m-dollar sales within three years

Israeli giant Teva, world leader on the generic drugs market, has placed Romania on its list of priorities for the next few years for Central and Eastern Europe. The company targets sales worth 60 million dollars within the next three years and also a position...